Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
100%
Urinary Bladder Tumor
100%
Invasive Tumors
33%
Bladder Tumor
22%
Superficial Tumor
22%
Ligand Binding
11%
Binding Site
11%
Tumor
11%
Urinary Bladder
11%
Competitive Binding
11%
Invasive Bladder Cancer
11%
Tumor Progression
11%
Activation Mechanism
11%
Tumor Cell Membrane
11%
Muscle Invasion
11%
Established Cell Lines
11%
High-affinity Receptor
11%
Biochemical Characteristics
11%
Bladder mucosa
11%
Calcium-activated
11%
Binding Analysis
11%
Scatchard Analysis
11%
Autophosphorylation
11%
Large Subgroup
11%
Selective Treatment
11%
EGF Ligands
11%
Medicine and Dentistry
Bladder Tumor
100%
Epidermal Growth Factor Receptor
100%
Tumor
55%
Cell Line
11%
Tumor Progression
11%
Invasive Bladder Cancer
11%
Binding Site
11%
Isotopes of Calcium
11%
Ligand Binding
11%
Autophosphorylation
11%
Iodine 125
11%
Bladder Mucosa
11%
Receptor Affinity
11%
Binding Competition
11%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Tumor
100%
Epidermal Growth Factor Receptor
100%
Receptor
11%
Tumor Growth
11%
Bladder Cancer
11%
Binding Site
11%
Iodine-125
11%
Immunology and Microbiology
Epidermal Growth Factor
100%
Cell Line
11%
Muscle
11%
Binding Site
11%
Ligand Binding
11%
Autophosphorylation
11%
Binding Competition
11%
Iodine-125
11%
Receptor Affinity
11%
Bladder Mucosa
11%
Neuroscience
Epidermal Growth Factor Receptor
100%
Binding Site
11%
Ligand Binding
11%
Cell Line
11%
Bladder Mucosa
11%
Receptor Affinity
11%
Iodine-125
11%
Binding Competition
11%